Livent, a top lithium mining stock, has faced volatility due to fluctuating demand and supply of lithium in response to booming EV and HEV sales. Lithium prices have fallen dramatically over the past ...

Livent Corporation has sold off due to falling lithium prices, but offers upside potential from the demand for EVs and new mining assets. The stock is already cheap, with a market cap of $3.7 billion, ...

Livent is small, but a key merger could catapult it into one of the world's largest lithium suppliers. Even in tough times, Livent remains highly profitable. This will be a story of executing on ...

The element lithium has had a resurgence in public awareness -- and investment popularity. Originally, it was an ingredient in pharmaceuticals and later an additive used in all sorts of manufacturing.

ILiAD (Integrated Lithium Adsorption Desorption) is a technology platform to extract lithium. Commercial utilization of ILiAD at Livent is expected to begin as early as 2025. Ready to turn the ...

Major lithium producers Albemarle (NYSE: ALB) and Livent (NYSE: LTHM) reported their second-quarter 2023 results this past week. So investors can now compare their results in their lithium businesses.

Livent’s LTHM second-quarter results exemplified our near-term outlook for the company and lithium producers in general. Adjusted EBITDA grew 42% versus the prior-year quarter driven primarily by ...

SAN DIEGO, Dec. 14, 2023 /PRNewswire/ -- Today, ILiAD Technologies, LLC and Livent Corporation (NYSE:LTHM) announced an agreement whereby Livent has acquired a minority stake in the parent company of ...

SYDNEY, Nov 12 (Reuters) - U.S lithium major Livent (LTHM.N), opens new tab will begin meeting Allkem (AKE.AX), opens new tab Australian investors from Monday ahead of a vote next month to approve a ...

Second-quarter revenue grew 8% year over year, missing the 16% growth Wall Street had expected. Adjusted earnings per share jumped 38%, exceeding the 27% increase analysts had projected. Management ...

(Reuters) - Lithium producer Livent Corp fell 3.6 percent in its market debut on Thursday after being priced at the lower end of its expected range, as investors worried about the recent declines in ...